Page 103 - Review Process News Today

Prevent crime. and so far -- so, for that reason, they have an aggressive posture. they go after people they believe are committing crimes. and you see just how aggressive they were in the opening moments of the video that were released. that unit right now is not operating here in the city of memphis. the mayor announced that theyve been inactive since this incident. the familys calling for them to end that unit, disband that unit. >> when i spoke to the police department earlier, they said tha...

Of dead enemies. and that was full of human remains of different communities in the world — different communities in the world. so in 2020 we took the human— world. so in 2020 we took the human remains off display, after— human remains off display, after quite an elaborate process of doing an ethical review— process of doing an ethical review of the museum. museum received — review of the museum. museum received quite a bit of critique, from academics but also — critique, from academ...

Force. i believe we had a failure in supervision and there was no appropriate oversight to ensure these officers were doing what they were supposed to do. >> reporter: the memphis police has not responded to specific allegations of previous use of excessive force by the scorpion unit. memphis police tell cnn that unit and all other specialized units of the department will undergo a review and that the scorpion unit is, quote, inactivated during the review process. brian todd, cnn, washington. >>...

It is horrific. it starts off with the body-worn camera video. yes, we have been able to see some of it. regarding this scorpion unit, im getting information now as were speaking from the police department that is just coming in, and theyve been talking about whats happening here. what theyre saying is theres been -- you know these calls from the family and from others about disbanding this unit, the police department is saying there will be a review over all specialized units currently the scor...

Classified documents, does that politically take the heat off of everyone? >> to some degree it does. listen, obviously theres still a legal review process going on here, and donald trump probably faces more legal peril, it seems at this moment than joe biden or mike pence. look at donald trumps statement supporting mike pence when this news was revealed? this is somebody hes been hammering against for the last year? he welcomes this to what you call a group. it now muddies the waters. you hear ...

The New Jersey Attorney General recently announced a settlement in its lawsuit against Yellowstone Capital LLC, its parent company, and various subsidiaries and affiliates alleging that...

Found in his private office. a source says ten obama-era documents were made up for a briefing material and intelligence memos. >> they were related, we now know, to iran, ukraine and the united kingdom. cnns phil mattingly at the white house and manu raju on capitol hill. so, phil, what is the white house saying about this? >> reporter: very little today. we obviously have the on the record statement from the white house counsels office last night detailing the time line of when these documents...

They are losing time. the association estimates a an average of 2,000 americans 65 and older per day will progress from mild toed a advanced alzheimers without drug treatment. the approval is not without controversy. a recent congressional investigation issued a scathing report on the fdas rushed approval of another alzheimers drug from the same u.s. developer. biogen, calling the review process highly a tipple and $56 per year price tag for that drug unjustifiably high. because of that price ta...

Two House of Representatives committees – Oversight and Reform, and Energy and Commerce – have published a report exposing the Food and Drug Administration (FDA) for "collaborat[ing]" [...]

A staff report by two House committees points to alleged irregularities in the Food and Drug Administration's approval of the Alzheimer's drug Aduhelm. "The High Price of Aduhelm's Approval: An Investigation into FDA's Atypical Review Process and Biogen's Aggressive Launch Plans" was released by the Committee on Oversight and Reform and Committee on Energy and Commerce after